Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Allarity Therapeutics Inc
ALLR
Healthcare
Biotechnology
Allarity Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing personalized cancer treatments. The Company is focused on development of stenoparib, a poly-ADP-ribose polymerase/Tankyrase inhibitor for advanced ovarian cancer patients, using its DRP companion diagnostic for patient selection in the ongoing phase 2 clinical trial, NCT03878849. It has in-licensed the...
intellectual property rights to develop, use and market stenoparib. Its DRP companion diagnostic platform is a predictive biomarker technology that employs complex systems biology and bio-analytics with a clinical relevance filter to bridge the gap between in vitro cancer cell responsiveness to a given therapeutic candidate and in vivo likelihood of actual patient benefit from that therapeutic candidate. Its DRP companion diagnostic platform provides a gene expression signature, which reveals whether a specific tumor in a specific patient is likely to respond to one of its therapeutic candidates.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ALLR)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 06, 2024 11:46am
ALLR.....More lies this a.m
Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1 2024-05-06 05:00 ET - News Release - Stockholders’ equity
...more
(91)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on May 02, 2024 10:00am
Allarity Therapeutics' Stenoparib Shows Clear Clinical Benef
Breaking News: $ALLR Allarity Therapeutics' Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian CancerBoston (May
...more
CLOUD DX Signs Multi-Year Contract with Provincial Health Authority
posted May 07, 2024 9:00am by
Cloud DX Inc.
-
|
The company is pleased to announce the execution on April 23, 2024 of a Remote Patient Monitoring Agreement for Cloud DX RPM Services with a Canadian Provincial Health Authority. This agreement is the 4th Provincial Health Authority contract for Cloud DX remote patient monitoring (RPM) services, alongside Alberta, the Yukon and Prince Edward Island. The contract has a term of 36 months with 2 extensions of 12 months each. The average contract value of each individual subscription is expected to be approximately ...read more
(91)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 12, 2024 11:30am
Allarity Therapeutics Inc. (NASDAQ: ALLR) Near the Top of Eq
Just In: $ALLR Allarity Therapeutics Inc. (NASDAQ: ALLR) Near the Top of Equities by Percentage Gain on 4/12Allarity Therapeutics Inc (NASDAQ: ALLR) is one of today's top gainers. The company'
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 12, 2023 6:00am
New Press Release - Allarity Therapeutics Announces Thomas Jensen as Interim CEO and Appointment of Jeremy R. Graff, PhD as Key Executive Advisor
Boston (December 12, 2023) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care, today announced a transition...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 05, 2023 3:57pm
ALLR ....what chit show ; )
F'king ridiculous how they let this happen I feel for the losers
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 05, 2023 2:55pm
ALLR.....I told you right from the opening bell
this was a train wreck waiting to happen N.L.O.D............ 50 cents You've all been had....again!!!!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 05, 2023 1:50pm
ALLR .... I told the Maggot what I was going to do
SH removed my post....LoL You guys can't handle the truth They can lie like a rug but I can't say squat !!!!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 05, 2023 1:38pm
ALLR...ya gotta churn it to earn it to burn it
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001860657/000121390023092856/ea188467-s1a1_allarity.htm
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 05, 2023 1:37pm
ALLR ....I lied ..... buh bye
All over but the cryin now No position
(61)
•••
Nibinator
X
View Profile
View Bullboard History
Post by
Nibinator
on Dec 05, 2023 1:33pm
Barrons as them 350$
Dang not on wealth easy
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 05, 2023 1:24pm
ALLR....now make me money dbag !
LoL
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 05, 2023 1:08pm
ALLR ....come on ....I dare ya!
55 cent low....good news hits hard
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 05, 2023 12:25pm
ALLR.....Ya have to look at the bright side.....
Just think how all those people who bought the last financing at $4.50 feel Pretty f'ing mad I'd say
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 05, 2023 12:06pm
ALLR ....when you look at the way it traded
The obvious trend was all down......hardly a sideways price action whatsoever Learn to use your eyes
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 05, 2023 12:03pm
ALLR ..... SH removed my honest Post ...again
I just tell it like it is
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
A Leading Provider in Virtual Healthcare Adds 4th Provincial Health Authority Contract
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market